A bacteriocin-based treatment option for Staphylococcus haemolyticus biofilms
Abstract Bacteriocins are ribosomally-synthesized antimicrobial peptides, showing great potential as novel treatment options for multidrug-resistant pathogens. In this study, we designed a novel hybrid bacteriocin, Hybrid 1 (H1), by combing the N-terminal part and the C-terminal part of the related...
Saved in:
Main Authors: | Christian Kranjec, Sofie S. Kristensen, Karolina T. Bartkiewicz, Mikkel Brønner, Jorunn P. Cavanagh, Aparna Srikantam, Geir Mathiesen, Dzung B. Diep |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/4bb49ca80ceb456895b33b7ca266dcc3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathogenesis of Staphylococcus haemolyticus on primary human skin fibroblast cells
by: Hala O. Eltwisy, et al.
Published: (2020) -
The Non-Lantibiotic Bacteriocin Garvicin Q Targets Man-PTS in a Broad Spectrum of Sensitive Bacterial Genera
by: Aleksandra Tymoszewska, et al.
Published: (2017) -
Distribution of Staphylococcus haemolyticus as the most dominant species among Staphylococcal infections at the Zainoel Abidin Hospital in Aceh, Indonesia
by: SUHARTONO, et al.
Published: (2019) -
Comprehensive analysis of bacteriocins in Streptococcus mutans
by: Atsuko Watanabe, et al.
Published: (2021) -
Bacteriocin-mediated inhibition of some common pathogens by wild and mutant Lactobacillus species and in vitro amplification of bacteriocin encoding genes
by: Arooj Ahsan, et al.
Published: (2021)